IRVINE, Calif. – November 11, 2025 – BioDuro, a trusted global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the appointment of Mr. Yaohui Ji as Global President, CMC. In this role, Mr. Ji will lead BioDuro's global chemistry, manufacturing and controls (CMC) organization, driving strategic planning, operations, and the continued expansion of the company's development and manufacturing capabilities.
Mr. Ji brings nearly two decades of leadership experience across leading global pharmaceutical companies and CDMOs, including Roche US, Novartis CN, WuXi STA (a CDMO subsidiary of WuXi AppTec), and Porton Pharma Solutions. Most recently, he served as Senior Vice President & General Manager of Porton's global small-molecule CDMO business, where he led a USD 300 million division with over 1,500 employees across the U.S., Europe, and China. Under his leadership, the division achieved a three-year compound annual growth rate (CAGR) of more than 50% through the successful execution of a strategic expansion plan.
In addition to driving rapid commercial growth, Mr. Ji played a pivotal role in transforming Porton from a traditional CMO to a fully integrated CDMO, building a world-class technology platform with over 100 scientists and engineers.
"Yaohui brings an exceptional combination of scientific depth, operational excellence, and strategic vision," said Armin Spura, Chief Executive Officer of BioDuro. "His proven track record in scaling global CDMO operations and driving innovation will further strengthen our CMC capabilities and accelerate our mission to deliver integrated drug development to our clients worldwide."
Mr. Ji holds a Master's from Brown University, Rhode Island, and a Bachelor's from the University of Science and Technology of China, Hefei. He holds three international patents and has authored multiple journal articles in the fields of pharmaceutical R&D and compliance management.
About BioDuro
BioDuro, an Advent International portfolio company, is a CRDMO with a 29-year proven track record. Headquartered in Irvine, California, USA, our global presence spans 7 sites across the United States and China, and over 2,000 employees. Specializing in both small and large molecule discovery, development, scale-up, and manufacturing, we offer fully integrated services from early drug discovery to commercial manufacturing across chemistry, biology, drug metabolism and pharmacokinetics (DMPK), drug substance, and drug product.
Media Enquiries
Christina Coby
Associate Director, BioDuro
Email: christina.coby@bioduro.com
Mobile: +1 (619) 414 7409
Chris Halling
Director, Communications & Content, Orientation Marketing
Email: Chris.Halling@orientation.agency
Mobile: +44 (0)7580 041073
Home
